Recently we reported that inhibition of PDC activity via enhanced expression of PDK2 contributes to the Warburg metabolic and malignant phenotype in human HNSCC; and inhibition of PDK2 lowers the phosphorylation of PDHα and reverts the Warburg metabolic and malignant phenotype [11]. The gene discussed is PDK2; the disease is head and neck squamous cell carcinoma.